Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Ray WA, Stein CM, Murray KT, Fuchs DC, Patrick SW, Daugherty J, Hall K, Cooper WO. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2018:12 de diciembre. [Ref.ID 102895]
2.Enlace a cita original Cita con resumen
Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel Jr EF, Grijalva CG. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018;168:20 de marzo. [Ref.ID 102563]
3. Cita con resumen
Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM. Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding. Gastroenterology 2016:14 de septiembre. [Ref.ID 100803]
4.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
5. Cita con resumen
Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA 2016;315:2415-23. [Ref.ID 100421]
6.Tiene citas relacionadas
Ray WA, Murray KT, Stein CM. Azithromycin and the risk of cardiovascular death. Author/editor response. N Engl J Med 2012;367:775. [Ref.ID 93628]
7. Cita con resumen
Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365:1896-904. [Ref.ID 91594]
8.Tiene citas relacionadas
Stein CM, Ray WA. The ethics of placebo in studies with fracture end points in osteoporosis. N Engl J Med 2010;363:1367-70. [Ref.ID 89434]
9. Cita con resumen
Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors. A cohort study. Ann Intern Med 2010;152:337-45. [Ref.ID 88125]
10.Tiene citas relacionadas
Ray WA, Murray KT, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. The authors reply. N Engl J Med 2009;360:2137-8. [Ref.ID 85840]
11.Enlace a cita original
Grijalva CG, Chung CP, Stein CM, Gideon PS, Dyer SM, Mitchel Jr EF, Griffin MR. Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2008;17:890-5. [Ref.ID 83995]
12.Tiene citas relacionadas Cita con resumen
Ray WA, Stein CM. Aprotinin and lysine analogues in high-risk cardiac surgery. The editorialists reply. N Engl J Med 2008;359:1181-2. [Ref.ID 83935]
13.Tiene citas relacionadas Cita con resumen
Stein CM, Roden DM, Schwarz UI. Genetics of warfarin response. The authors reply. N Engl J Med 2008;358:2743-4. [Ref.ID 83290]
14.Tiene citas relacionadas Cita con resumen
Ray WA, Stein CM. The aprotinin story - Is BART the final chapter?. N Engl J Med 2008;358:2398-400. [Ref.ID 83034]
15.Tiene citas relacionadas Cita con resumen
Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008;358:999-1008. [Ref.ID 82422]
16. Cita con resumen
Ray WA, Stein CM. Reform of drug regulation - beyond ann independent drug-safety board. N Engl J Med 2006;354:194-201. [Ref.ID 75808]
17. Cita con resumen
Ray W A, Griffin MR, Stein CM. Cardiovascular toxicity of valdecoxib. N Engl J Med 2004;351:2767. [Ref.ID 72547]
18.Tiene citas relacionadas Cita con resumen
Ray W A, Murray KT, Meredith S, Narasimhulu S S, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089-96. [Ref.ID 71303]
19. Cita con resumen
Griffin MR, Stein CM, Graham DJ, Daugherty JR, Arbogast PG, Ray W A. High frequency of use of rofecoxib at greater than recommended doses: cause for concern. Pharmacoepidemiol Drug Saf 2004;13:339-43. [Ref.ID 70400]
20.
Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004;350:2167-9. [Ref.ID 70054]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>